Cryoport (CYRX) Competitors $6.57 -0.36 (-5.19%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CYRX vs. ZNTL, IGMS, IRWD, AUPH, DAWN, TVTX, PRAX, SAVA, SNDX, and SPRYShould you be buying Cryoport stock or one of its competitors? The main competitors of Cryoport include Zentalis Pharmaceuticals (ZNTL), IGM Biosciences (IGMS), Ironwood Pharmaceuticals (IRWD), Aurinia Pharmaceuticals (AUPH), Day One Biopharmaceuticals (DAWN), Travere Therapeutics (TVTX), Praxis Precision Medicines (PRAX), Cassava Sciences (SAVA), Syndax Pharmaceuticals (SNDX), and ARS Pharmaceuticals (SPRY). These companies are all part of the "pharmaceutical preparations" industry. Cryoport vs. Zentalis Pharmaceuticals IGM Biosciences Ironwood Pharmaceuticals Aurinia Pharmaceuticals Day One Biopharmaceuticals Travere Therapeutics Praxis Precision Medicines Cassava Sciences Syndax Pharmaceuticals ARS Pharmaceuticals Cryoport (NASDAQ:CYRX) and Zentalis Pharmaceuticals (NASDAQ:ZNTL) are both small-cap transportation companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, community ranking, risk, profitability, media sentiment and institutional ownership. Does the MarketBeat Community favor CYRX or ZNTL? Cryoport received 182 more outperform votes than Zentalis Pharmaceuticals when rated by MarketBeat users. Likewise, 64.96% of users gave Cryoport an outperform vote while only 63.44% of users gave Zentalis Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCryoportOutperform Votes24164.96% Underperform Votes13035.04% Zentalis PharmaceuticalsOutperform Votes5963.44% Underperform Votes3436.56% Do analysts recommend CYRX or ZNTL? Cryoport presently has a consensus price target of $12.50, suggesting a potential upside of 90.26%. Zentalis Pharmaceuticals has a consensus price target of $10.00, suggesting a potential upside of 219.49%. Given Zentalis Pharmaceuticals' higher probable upside, analysts clearly believe Zentalis Pharmaceuticals is more favorable than Cryoport.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cryoport 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Zentalis Pharmaceuticals 0 Sell rating(s) 5 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.44 Does the media prefer CYRX or ZNTL? In the previous week, Zentalis Pharmaceuticals had 22 more articles in the media than Cryoport. MarketBeat recorded 25 mentions for Zentalis Pharmaceuticals and 3 mentions for Cryoport. Cryoport's average media sentiment score of 0.96 beat Zentalis Pharmaceuticals' score of 0.63 indicating that Cryoport is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cryoport 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zentalis Pharmaceuticals 4 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in CYRX or ZNTL? 92.9% of Cryoport shares are owned by institutional investors. 10.1% of Cryoport shares are owned by insiders. Comparatively, 3.6% of Zentalis Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, CYRX or ZNTL? Cryoport has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Comparatively, Zentalis Pharmaceuticals has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500. Which has higher valuation and earnings, CYRX or ZNTL? Cryoport has higher revenue and earnings than Zentalis Pharmaceuticals. Cryoport is trading at a lower price-to-earnings ratio than Zentalis Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCryoport$233.26M1.39-$99.59M-$3.38-1.94Zentalis PharmaceuticalsN/AN/A-$292.19M-$2.49-1.26 Is CYRX or ZNTL more profitable? Zentalis Pharmaceuticals has a net margin of 0.00% compared to Cryoport's net margin of -70.08%. Cryoport's return on equity of -13.35% beat Zentalis Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Cryoport-70.08% -13.35% -6.43% Zentalis Pharmaceuticals N/A -43.91%-34.96% SummaryCryoport beats Zentalis Pharmaceuticals on 10 of the 17 factors compared between the two stocks. Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. Get Cryoport News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYRX vs. The Competition Export to ExcelMetricCryoportPharmaceutical IndustryTransportation SectorNASDAQ ExchangeMarket Cap$324.76M$6.44B$331.28B$8.82BDividend YieldN/A8.11%4.48%4.07%P/E Ratio-1.9410.6117.8317.74Price / Sales1.39243.7555.5574.25Price / Cash17.8722.169.0732.53Price / Book0.705.472.214.68Net Income-$99.59M$153.61M$570.30M$226.08M7 Day Performance-14.34%-4.32%-1.41%-2.03%1 Month Performance-12.98%-8.61%-1.71%0.07%1 Year Performance-52.63%28.79%13.46%24.61% Cryoport Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYRXCryoport2.7225 of 5 stars$6.57-5.2%$12.50+90.3%-52.6%$342.80M$233.26M-1.941,170Insider TradeZNTLZentalis Pharmaceuticals2.5838 of 5 stars$3.13+4.7%$10.00+219.5%-71.1%$213.08MN/A0.00160Analyst RevisionIGMSIGM Biosciences4.7018 of 5 stars$9.77+2.4%$16.13+65.1%+63.3%$567.29M$2.13M0.00190IRWDIronwood Pharmaceuticals4.2676 of 5 stars$3.52-7.6%$10.40+195.5%-63.0%$609.71M$442.73M0.00220AUPHAurinia Pharmaceuticals1.6758 of 5 stars$8.24+1.4%$10.00+21.4%-10.8%$1.16B$175.51M0.00300DAWNDay One Biopharmaceuticals1.9859 of 5 stars$13.62+0.7%$35.71+162.2%+12.4%$1.36BN/A0.0060Positive NewsTVTXTravere Therapeutics2.9019 of 5 stars$17.86+2.7%$22.62+26.6%+210.6%$1.36B$145.24M0.00460PRAXPraxis Precision Medicines1.754 of 5 stars$73.68+1.3%$146.33+98.6%+299.3%$1.36B$2.45M0.00110SAVACassava Sciences3.8385 of 5 stars$26.05-7.0%$111.50+328.0%+59.6%$1.35BN/A0.0030SNDXSyndax Pharmaceuticals4.0038 of 5 stars$15.95+1.1%$37.18+133.1%+3.4%$1.35B$139.71M0.00110Analyst ForecastAnalyst RevisionSPRYARS Pharmaceuticals2.734 of 5 stars$13.55-1.7%$24.00+77.1%+183.5%$1.34B$30,000.000.0090Analyst Revision Related Companies and Tools Related Companies Zentalis Pharmaceuticals Competitors IGM Biosciences Competitors Ironwood Pharmaceuticals Competitors Aurinia Pharmaceuticals Competitors Day One Biopharmaceuticals Competitors Travere Therapeutics Competitors Praxis Precision Medicines Competitors Cassava Sciences Competitors Syndax Pharmaceuticals Competitors ARS Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CYRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryoport, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryoport With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYRX Stock Alerts